Correlation Between OSE Pharma and Europlasma
Can any of the company-specific risk be diversified away by investing in both OSE Pharma and Europlasma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OSE Pharma and Europlasma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OSE Pharma SA and Europlasma SA, you can compare the effects of market volatilities on OSE Pharma and Europlasma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OSE Pharma with a short position of Europlasma. Check out your portfolio center. Please also check ongoing floating volatility patterns of OSE Pharma and Europlasma.
Diversification Opportunities for OSE Pharma and Europlasma
-0.6 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between OSE and Europlasma is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding OSE Pharma SA and Europlasma SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Europlasma SA and OSE Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OSE Pharma SA are associated (or correlated) with Europlasma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Europlasma SA has no effect on the direction of OSE Pharma i.e., OSE Pharma and Europlasma go up and down completely randomly.
Pair Corralation between OSE Pharma and Europlasma
Assuming the 90 days trading horizon OSE Pharma SA is expected to under-perform the Europlasma. But the stock apears to be less risky and, when comparing its historical volatility, OSE Pharma SA is 12.21 times less risky than Europlasma. The stock trades about -0.26 of its potential returns per unit of risk. The Europlasma SA is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest 6.55 in Europlasma SA on September 2, 2024 and sell it today you would earn a total of 2.95 from holding Europlasma SA or generate 45.04% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
OSE Pharma SA vs. Europlasma SA
Performance |
| Timeline |
| OSE Pharma SA |
| Europlasma SA |
OSE Pharma and Europlasma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with OSE Pharma and Europlasma
The main advantage of trading using opposite OSE Pharma and Europlasma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OSE Pharma position performs unexpectedly, Europlasma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Europlasma will offset losses from the drop in Europlasma's long position.| OSE Pharma vs. Innate Pharma | OSE Pharma vs. Quantum Genomics SA | OSE Pharma vs. Valneva SE | OSE Pharma vs. Poxel SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |